Sectors
Foley & Lardner LLP advised XRHealth, the leading platform for therapeutic technologies, on its acquisition of PursueCare, a virtual health care provider delivering personalized addiction treatment for alcohol, opioids, cannabis, kratom and 7-OH, and co-occurring mental health conditions.
Through the acquisition, XRHealth will add PursueCare’s multidisciplinary telehealth services as well as its FDA-authorized prescription digital therapeutics RESET® and RESET-O®, which deliver evidence-based cognitive behavioral therapy and contingency management through a smartphone. The acquisition further advances XRHealth’s vision for a connected health care ecosystem that extends personalized care across AR and VR glasses, smartphones, smartwatches, and other digital devices.
The Foley team served as legal counsel for health care regulatory issues and was led by partner Thomas (T.J.) Ferrante, vice chair of the firm’s nationally recognized Health Care Practice Group, and included support from of counsel Amy Lerman and associates Bradley Henson and Chana Gandelsman.
The Telemedicine & Digital Health Industry Team helps venture-backed and high-growth companies embrace emerging issues in virtual care, enabling them to provide innovative care for patients in new markets around the block and around the world. Foley is committed to helping entrepreneurs fulfill their goals of harnessing new technology to reach patients anywhere, delivering care without borders or geographic limitations. The firm helps create fully-fledged telemedicine offerings, providing end-to-end legal services by coupling precise strategic guidance with rapid turnarounds to maintain that sense of urgency necessary to launch new initiatives and remain competitive in the marketplace. Learn more at www.foley.com/telemedicine.
